Evidence map›Paper›PMID 41078366›Full record

ArticleFrontiers in cellular and infection microbiology2025

The reticulocyte restriction: invasion ligand RBP1a of

Jessica Molina-Franky, Daniel Röth, Monica Ararat-Sarria, Manuel Alfonso Patarroyo, Markus Kalkum

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jessica Molina-FrankyDepartment of Immunology and Theranostics, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute of the City of Hope, Duarte, CA, United States.
Daniel RöthDepartment of Immunology and Theranostics, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute of the City of Hope, Duarte, CA, United States.
Monica Ararat-SarriaGrupo de Investigación Básica en Biología Molecular e Inmunología (GIBBMI), Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia.
Manuel Alfonso PatarroyoGrupo de Investigación Básica en Biología Molecular e Inmunología (GIBBMI), Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia.
Markus KalkumDepartment of Immunology and Theranostics, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute of the City of Hope, Duarte, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: The erythroid cell lines JK-1 and BEL-A were evaluated Results: We confirmed that the JK-1 cell line supports Conclusion: Our findings provide novel insights into the molecular mechanisms underlying reticulocyte restriction in

Indexed as

Antigens, CDBasiginPlasmodium vivaxProtozoan ProteinsReceptors, TransferrinRepressor ProteinsReticulocytesCell LineChromatography, LiquidErythrocytesHumansMalaria, VivaxMembrane ProteinsProhibitinsProtein BindingProteomicsAntigens, CDBasiginBSG protein, humanCD71 antigenMembrane ProteinsPHB2 protein, humanProhibitinsProtozoan ProteinsReceptors, TransferrinRepressor Proteinsreticulocyte-binding protein, Plasmodium vivaxerythroid cell linesLC-MS proteomicsmembrane proteomicsparasite invasionPlasmodium vivaxreceptor-ligand interactions

Identifiers

PMID41078366
PMCPMC12507909

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.